155 related articles for article (PubMed ID: 33201124)
21. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
[TBL] [Abstract][Full Text] [Related]
22. Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy.
Samson P; Puri V; Broderick S; Patterson GA; Meyers B; Crabtree T
Ann Thorac Surg; 2017 Feb; 103(2):406-415. PubMed ID: 28024648
[TBL] [Abstract][Full Text] [Related]
23. Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy.
Wong J; Weber J; Almhanna K; Hoffe S; Shridhar R; Karl R; Meredith KL
J Gastrointest Surg; 2013 Sep; 17(9):1562-8; discussion 1569. PubMed ID: 23818125
[TBL] [Abstract][Full Text] [Related]
24. Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients.
Künzli HT; van Berge Henegouwen MI; Gisbertz SS; van Esser S; Meijer SL; Bennink RJ; Wiezer MJ; Seldenrijk CA; Bergman JJGHM; Weusten BLAM
Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881907
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Tumor Regression on Prognosis After Neoadjuvant Chemoradiotherapy in Surgically Treated Esophageal Adenocarcinoma.
Crull DJ; Hogenes MCH; Hoekstra R; Hendriksen EM; van Det MJ; Kouwenhoven EA
Ann Surg Oncol; 2022 Jun; 29(6):3658-3666. PubMed ID: 35094189
[TBL] [Abstract][Full Text] [Related]
27. Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better?
de Geus SWL; Hirji S; Hachey KJ; Sachs TE; Suzuki K; Ng SC; Swanson S; Litle VR; D'Amico T; Tseng JF
J Gastrointest Surg; 2020 Nov; 24(11):2447-2455. PubMed ID: 32875442
[TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
29. Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Hulshoff JB; Faiz Z; Karrenbeld A; Kats-Ugurlu G; Burgerhof JG; Smit JK; Plukker JT
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1301-9. PubMed ID: 26314875
[TBL] [Abstract][Full Text] [Related]
30. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
31. TRANSHIATAL ESOPHAGECTOMY IS NOT ASSOCIATED WITH POOR QUALITY LYMPHADENECTOMY.
Takeda FR; Tustumi F; Nigro BC; Sallum RAA; Ribeiro-Junior U; Cecconello I
Arq Bras Cir Dig; 2019; 32(4):e1475. PubMed ID: 31859928
[TBL] [Abstract][Full Text] [Related]
32. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
[TBL] [Abstract][Full Text] [Related]
33. Impact of Lymphadenectomy on Survival After Unimodality Transthoracic Esophagectomy for Adenocarcinoma of Esophagus.
Phillips AW; Hardy K; Navidi M; Kamarajah SK; Madhavan A; Immanuel A; Griffin SM
Ann Surg Oncol; 2020 Mar; 27(3):692-700. PubMed ID: 31605326
[TBL] [Abstract][Full Text] [Related]
34. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
35. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
[TBL] [Abstract][Full Text] [Related]
36. Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis.
Zhang Y; Cao Y; Zhang J; Huang M; Roy P; Huang B; Yang H; Rong Y; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Lin J; Zhang J; Fu J; He J; Li H
Ann Surg; 2023 Jun; 277(6):e1239-e1246. PubMed ID: 35797545
[TBL] [Abstract][Full Text] [Related]
37. Extent of lymph node removal during esophageal cancer surgery and survival.
van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
[TBL] [Abstract][Full Text] [Related]
38. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
39. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
[TBL] [Abstract][Full Text] [Related]
40. Impact of increasing lymph node yield on staging, morbidity and survival after esophagectomy for esophageal adenocarcinoma.
Henckens SPG; Hagens ERC; van Berge Henegouwen MI; Meijer SL; Eshuis WJ; Gisbertz SS
Eur J Surg Oncol; 2023 Jan; 49(1):89-96. PubMed ID: 35933270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
